FDA Inspection 1091073 — Hans Biomed Corporation
The FDA completed an inspection of Hans Biomed Corporation on Apr 5, 2019 in Yuseong District. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 5, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Yuseong District (Korea (the Republic of))